Cambridge Antibody Technology Group PLC (UK) - Shares in Issue Update
Changes In FTSE Indices

22 December 2004


Following a shares in issue update for Cambridge Antibody Technology Group PLC (UK), FTSE announces the following changes:

INDEXCHANGEEFFECTIVE FROM
START OF TRADING
FTSE All-ShareCambridge Antibody Technology Group (UK 0166225) will remain in the index with an increased shares in issue total of 51,335,100 and an unchanged investability weighting of 100%.31 December 2004
FTSE CAP All-ShareCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE All-Share Ex-MultinationalsCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE All-SmallCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE SmallCapCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE techMARK 100Cambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE techMARK All-ShareCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE techMARK mediscienceCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE4Good UK IndexCambridge Antibody Technology Group will be treated as above.31 December 2004
FTSE ISS UK CGICambridge Antibody Technology Group will be treated as above.31 December 2004


For index related enquiries or further information about FTSE please contact:
Client Services in UK:Tel: +44 (0) 20 7448 1810
Client Services in US:Tel: +1 888 747 FTSE (3873) or +1 212 641 6166
Client Services in Asia Pacific:Tel: +852 2230 5800 or +65 6223 3738 or +81 3 3581 2796

Or, email your enquiries to info@ftse.com or visit our website at www.ftse.com


Terms of Use | Copyright © FTSE